Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia

Abstract Objective To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia. Methods We evaluated 154 individuals who were assessed with amyloid‐β PET with [18...

Full description

Bibliographic Details
Main Authors:	Joseph Therriault, Tharick A. Pascoal, Marcus Sefranek, Sulantha Mathotaarachchi, Andrea L. Benedet, Mira Chamoun, Firoza Z. Lussier, Cécile Tissot, Bruna Bellaver, Pamela Lukasewicz Ferreira, Eduardo R. Zimmer, Paramita Saha‐Chaudhuri, Serge Gauthier, Pedro Rosa‐Neto, the Alzheimer's Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Wiley 2021-10-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51457

Similar Items

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
by: Cécile Tissot, et al.
Published: (2021-01-01)

Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease
by: Gustavo Patow, et al.
Published: (2023-12-01)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly
by: Xiaofeng Li, et al.
Published: (2018-01-01)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
by: Guilherme Povala, et al.
Published: (2021-12-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01)

Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
by: Joseph Therriault, et al.
Published: (2023-07-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
by: Yue Cai, et al.
Published: (2023-02-01)

Nonlinear changes in delayed functional network topology in Alzheimer’s disease: relationship with amyloid and tau pathology
by: Mite Mijalkov, et al.
Published: (2023-06-01)

Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
by: Nicholas J. Ashton, et al.
Published: (2022-02-01)

The accuracy and robustness of plasma biomarker models for amyloid PET positivity
by: Andréa L. Benedet, et al.
Published: (2022-02-01)

Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
by: Elaheh Moradi, et al.
Published: (2024-02-01)

Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
by: Chae Jung Park, et al.
Published: (2022-09-01)

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
by: Omar A. Halawa, et al.
Published: (2019-01-01)

Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
by: Evan Fletcher, et al.
Published: (2018-01-01)

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
by: Zhi-Bo Wang, et al.
Published: (2022-12-01)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
by: Patrick J. Lao, et al.
Published: (2018-01-01)

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
by: Taylor J. Maxwell, et al.
Published: (2018-08-01)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
by: Alexa Pichet Binette, et al.
Published: (2022-11-01)

Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
by: Tengfei Guo, et al.
Published: (2021-10-01)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
by: Davina Biel, et al.
Published: (2023-02-01)

CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
by: Joel Simrén, et al.
Published: (2022-12-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Impact of long- and short-range fibre depletion on the cognitive deficits of fronto-temporal dementia
by: Melissa Savard, et al.
Published: (2022-01-01)

Development and evaluation of an automated quantification tool for amyloid PET images
by: Yuma Tsubaki, et al.
Published: (2020-09-01)

Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease
by: Marina Tedeschi Dauar, et al.
Published: (2023-01-01)

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
by: Hua Zhang, et al.
Published: (2018-08-01)

Language dysfunction correlates with cognitive impairments in older adults without dementia mediated by amyloid pathology
by: Chunchen Xiang, et al.
Published: (2023-05-01)

Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
by: Jung-Min Pyun, et al.
Published: (2024-02-01)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
by: Kok Pin Ng, et al.
Published: (2021-01-01)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
by: Shannon L. Risacher, et al.
Published: (2019-12-01)

Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.
by: Liyong Wu, et al.
Published: (2012-01-01)

Machine learning of brain structural biomarkers for Alzheimer's disease (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population
by: Akihiko Shiino, et al.
Published: (2021-01-01)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
by: Stockman, CA, et al.
Published: (2024)

Membrane-induced tau amyloid fibrils
by: Nadia El Mammeri, et al.
Published: (2023-04-01)

Membrane-induced tau amyloid fibrils
by: El Mammeri, Nadia, et al.
Published: (2024)

Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
by: Dawn C. Matthews, et al.
Published: (2022-01-01)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
by: Hyung-Ji Kim, et al.
Published: (2022-07-01)